Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior.

Miller CJ, Li M, Penfold RB, Lee AF, Smith EG, Osser DN, Bajor L, Bauer MS.

BMC Psychiatry. 2014 Nov 30;14:339. doi: 10.1186/s12888-014-0339-z.

2.

The effect of race-ethnicity and geography on adoption of innovations in the treatment of schizophrenia.

Horvitz-Lennon M, Alegría M, Normand SL.

Psychiatr Serv. 2012 Dec;63(12):1171-7.

3.

The effect of ethnicity on prescribing practice and treatment outcome in inpatients suffering from schizophrenia in Greece.

Douzenis A, Apostolopoulos A, Seretis D, Rizos EN, Christodoulou C, Lykouras L.

BMC Psychiatry. 2011 Apr 20;11:66. doi: 10.1186/1471-244X-11-66.

4.

Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder.

Stauffer VL, Sniadecki JL, Piezer KW, Gatz J, Kollack-Walker S, Hoffmann VP, Conley R, Durell T.

BMC Psychiatry. 2010 Nov 3;10:89. doi: 10.1186/1471-244X-10-89.

6.

Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder.

Busch AB, Huskamp HA, Neelon B, Manning T, Normand SL, McGuire TG.

Med Care. 2009 Dec;47(12):1217-28. doi: 10.1097/MLR.0b013e3181adcc4f.

7.

Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic.

Sajatovic M, Ignacio RV, West JA, Cassidy KA, Safavi R, Kilbourne AM, Blow FC.

Compr Psychiatry. 2009 Mar-Apr;50(2):100-7. doi: 10.1016/j.comppsych.2008.06.008. Epub 2008 Aug 23.

8.

Attitudes toward psychopharmacology among hospitalized patients from diverse ethno-cultural backgrounds.

Thorens G, Gex-Fabry M, Zullino DF, Eytan A.

BMC Psychiatry. 2008 Jul 9;8:55. doi: 10.1186/1471-244X-8-55.

Supplemental Content

Support Center